Kymos Group

📍 Cerdanyola del Vallès, Spain🗓 Founded 2001👥 198 employees💰 Last funded 2024
Pharmaceutical Manufacturing🌐 kymos.com
Website LinkedIn
Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones: i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines. ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies. iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing) iv) Process analytical technology services, using NIR and RAMAN and QbD strategies. Kymos is certified in GLPs and GMPs compliance and it has been authorized as partial manufacturer in quality control.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
2001
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Spain
2
Frequently asked questions
Who invested in Kymos Group?
Kymos Group has 2 investors on record on gritt.io.
When did Kymos Group last raise funding?
The most recent investment in Kymos Group recorded on gritt.io was in 2024.
When was Kymos Group founded?
Kymos Group was founded in 2001.
What industry is Kymos Group in?
Kymos Group operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Kymos Group based?
Kymos Group is headquartered in Cerdanyola del Vallès, Spain.